Clostridium difficile Infection Associated with Antineoplastic Chemotherapy: A Review

Clinical Infectious Diseases

Volumn 17, Issue 1, 1993, Pages 109-113

  Glatt, Aaron E ^a,b,c   Anand, Ajay ^a,b,c  

^a NASSAU UNIVERSITY MEDICAL CENTER   (United States)

^b Catholic Medical Center ^*  (Jamaica)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; CLOSTRIDIUM TOXIN; CYCLOPHOSPHAMIDE; CYTARABINE; DICHLOROMETHOTREXATE; DIPHENOXYLATE; DOXORUBICIN; FLUOROURACIL; LOPERAMIDE; MELPHALAN; METHOTREXATE; METRONIDAZOLE; PREDNISOLONE; TIOGUANINE; VANCOMYCIN; VINBLASTINE; VINCRISTINE;

ADULT; AGED; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BACTERIAL OVERGROWTH; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE; DIARRHEA; FECES CULTURE; FEMALE; FEVER; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; REVIEW;

ADULT; AGED; ANIMAL; ANTINEOPLASTIC AGENTS; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HAMSTERS; HUMAN; INTESTINES; MALE; MIDDLE AGE; NEOPLASMS;

EID: 0027175513     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/17.1.109     Document Type: Article

References (49)

1. Brown E, Talbot GH, Axelrod P, Provencher M, Hoegg C. Risk factors for Clostridium difficile toxin-associated diarrhea. Infect Control Hosp Epidemiol 1990;11:283-90.
2. George RH, Symonds JM, Dimock F, et al. Identification of Clostridium difficile as a cause of pseudomembranous colitis. BMJ 1978;1:695.
3. Bartlett JG, Chang TW, Taylor NS, Onderdonk AB. Colitis induced by Clostridium difficile. Rev Infect Dis 1979;1:370-8.
4. Tedesco J, Barton RW, Alpers DH. Clindamycin-associated colitis. A prospective study. Ann Intern Med 1974;81:429-33.
5. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 1978;298:531-4.
6. Rifkin GD, Fekety FR, Silva J, Sack RB. Antibiotic-induced colitis: implication of a toxin neutralised by Clostridium sordellii antitoxin. Lancet 1977;2:1103-6.
7. Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Clindamycin-associated colitis due to toxin-producing species of Clostridium in hamsters. J Infect Dis 1977;136:701-5.
8. Bartlett JG. Clostridium difficile: clinical considerations. Rev Infect Dis 1990;12(suppl 2):243-51.
9. Yee J, Dixon CM, McLean APH, Meakins JL. Clostridium difficile disease in a department of surgery. The significance of prophylactic antibiotics. Arch Surg 1991;126:241-6.
10. Gerding DN. Disease associated with Clostridium difficile infection. Ann Intern Med 1989;110:255-7.
11. Savage AM, Alford RH. Nosocomial spread of Clostridium difficile. Infect Control Hosp Epidemiol 1983;4:31-3.
12. Walters BAJ, Stafford R, Roberts RK, Seneviratne E. Contamination and crossinfection with Clostridium difficile in an intensive care unit. Aust N Z J Med 1982;12:255-8.
13. Nolan NPM, Kelly CP, Humphreys JFH, et al. An epidemic of pseudomembranous colitis: importance of person-to-person spread. Gut 1987;28:1467-73.
14. Moskowitz M, Bartlett JG. Recurrent pseudomembranous colitis unassociated with prior antibiotic therapy. Arch Intern Med 1981;141:663-4.
15. Bartlett JG, Gorbach SL. Pseudomembranous enterocolitis (antibioticrelated colitis). Adv Intern Med 1977;22:455-76.
16. Dosik GM, Luna M, Valdivieso M, et al. Necrotizing colitis in patients with cancer. Am J Med 1979;67:646-56.
17. Miller SD, Blake M, Miliotis M, Still C, Taubin A, KoornhofHJ. Antibiotic- associated diarrhoea and pseudomembranous colitis caused by Clostridium difficile: a review of forty cases. S Afr Med J 1983;63:936-9.
18. Cudmore MA, Silva J, Fekety R, Liepman MK, Kim KH. Clostrid-%UM difficile colitis associated with cancer chemotherapy. Arch Intern Med 1982;142:333-5.
19. Silva J, Fekety R, Werk C, et al. Inciting and etiologic agents of colitis. Rev Infect Dis 1984;6(suppl 1):S214-21.
20. George WL. Antimicrobial agent-associated colitis and diarrhea: historical background and clinical aspects. Rev Infect Dis 1984;6(suppl 1):208-13.
21. Taylor SG III, Hass GM, Crumrine JL, Slaughter DP. Toxic reactions of 4-amino-pteroylglutamic acid (aminopterin) in patients with faradvanced neoplastic disease. Cancer 1950;3:493-503.
22. Satin AJ, Harrison CR, Hancock KC, Zahn CM. Relapsing Clostridium difficile toxin-associated colitis in ovarian cancer patients treated with chemotherapy. Obstet Gynecol 1989;74:487-9.
23. Bruckner HW. Effect of antibiotics on mice treated with cyclophosphamide. J Natl Cancer Inst 1976;57:1249-52.
24. Chello PL, Bruckner HW. Inhibition of L5178Y cells in culture by methotrexate and antibiotics. Antimicrob Agents Chemother 1976;10:185-7.
25. Kamthan AG, Bruckner HW, Hirschman SZ, Agus SG. Clostridium difficile diarrhea induced by cancer chemotherapy. Arch Intern Med 1992;152:1715-7.
26. Baskerville A, Batter-Hatton D. Intestinal lesions induced experimentally by methotrexate. Br J Exp Pathol 1977;58:663-9.
27. Milles SS, Muggia AL, Spiro HM. Colonic histologic changes induced by 5-fluorouracil. Gastroenterology 1962;43:391-9.
28. White RS, Fuqua WB, Barrett O. The effect of 5-fluorouracil on small bowel mucosa. J Surg Oncol 1971;3:501-6.
29. Jeynes BJ, Altmann GG. Light and scanning electron microscopic observations of the effects of sublethal doses of methotrexate on the rat small intestine. Anat Rec 1978;191:1-17.
30. Allan SG, Smyth JF. Small intestinal mucosal toxicity of cis-platinum-comparison of toxicity with platinum analogues and dexamethasone. Br J Cancer 1986;53:355-60.
31. Slavin RE, Dias MA, Saral R. Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols. A clinical-pathologic study of 33 patients. Cancer 1978;42:1747-59.
32. Lyerly DM, Krivan HC, Wilkins TD. Clostridium difficile: its disease and toxins. Clin Microbiol Rev 1988;1:1-18.
33. Borriello SP. Pathogenesis of Clostridium difficile infection of the gut. J Med Microbiol 1990;33:207-15.
34. Fainstein V, Bodey GP, Fekety R. Relapsing pseudomembranous colitis associated with cancer chemotherapy [letter]. J Infect Dis 1981;143:865.
35. Miller SD, Koornhof HJ. Clostridium difficile colitis associated with the use of antineoplastic agents. Eur J Clin Microbiol 1984;3:10-3.
36. Roda PI. Clostridium difficile colitis induced by cytarabine. Am J Clin Oncol 1987;10:451-2.
37. Velanovich V, LaPorta AJ, Garrett WL, Richards TB, Cornett PA. Pseudomembranous colitis leading to toxic megacolon associated with antineoplastic chemotherapy. Report of a case and review of the literature. Dis Colon Rectum 1992;35:369-72.
38. Silva J Jr, Batts DH, Fekety R, Plouffe JF, Rifkin GD, Baird I. Treatment of Clostridium difficile colitis and diarrhea with vancomycin. Am J Med 1981;71:815-22.
39. Fekety R, Silva J, Buggy B, Deery HG. Treatment of antibiotic-associated colitis with vancomycin. J Antimicrob Chemother 1984;14(suppl D):97-102.
40. Tedesco F, Markham R, Gurwith M, Christie D, Bartlett JG. Oral vancomycin for antibiotic-associated pseudomembranous colitis. Lancet 1978;2:226-8.
41. Keighley MRB, Burdon DW, Arabi Y, et al. Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea. BMJ 1978;2:1667-9.
42. Teasley DG, Gerding DN, Olson MM, et al. Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis. Lancet 1983;2:1043-6.
43. George WL, Volpicelli NA, Stiner DB, et al. Relapse of pseudomembranous colitis after vancomycin therapy. N Engl J Med 1978;301:414-5.
44. Talbot RW, Walker RC, Beart RW. Changing epidemiology, diagnosis, and treatment of Clostridium difficile toxin-associated colitis. Br J Surg 1986;73:457-60.
45. Young GP, Bayley N, Ward P, St. John DJB, McDonald MI. Antibiotic- associated colitis caused by Clostridium difficile: relapse and risk factors. Med J Aust 1986;144:303-6.
46. Atherton LD, Leib ES, Kaye MD. Toxic megacolon associated with methotrexate therapy. Gastroenterology 1984;86:1583-8.
47. Larson HE, Price AB, Honour P, Borriello SP. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet 1978;1:1063-6.
48. Kaatz GW, Gitlin SD, Schaberg DR, et al. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 1988;127:1289-94.
49. McFarland LV, Stamm WE. Review of Clostridium difficile-associated diseases. Am J Infect Control 1986;14:99-109.